Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
Spector, S L; Smith, L J; Glass, M
American Journal of Respiratory & Critical Care Medicine.
150(3):618-623, September 1994.
(Format: HTML, PDF)